130 related articles for article (PubMed ID: 32099975)
1. Does Streptococcus Salivarius Strain M18 Assumption Make Black Stains Disappear in Children?
Bardellini E; Amadori F; Gobbi E; Ferri A; Conti G; Majorana A
Oral Health Prev Dent; 2020 Apr; 18(2):161-164. PubMed ID: 32099975
[TBL] [Abstract][Full Text] [Related]
2. Safety assessment of
Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
[TBL] [Abstract][Full Text] [Related]
3. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
Park JA; Lee GR; Lee JY; Jin BH
Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
[TBL] [Abstract][Full Text] [Related]
4. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
Karaçam S; Tunçer S
Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
[TBL] [Abstract][Full Text] [Related]
5. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.
Burton JP; Drummond BK; Chilcott CN; Tagg JR; Thomson WM; Hale JDF; Wescombe PA
J Med Microbiol; 2013 Jun; 62(Pt 6):875-884. PubMed ID: 23449874
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
Yoo HJ; Jwa SK; Kim DH; Ji YJ
Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus salivarius Probiotics to Prevent Acute Otitis Media in Children: A Randomized Clinical Trial.
Sarlin S; Koskela U; Honkila M; Tähtinen PA; Pokka T; Renko M; Tapiainen T
JAMA Netw Open; 2023 Nov; 6(11):e2340608. PubMed ID: 37917062
[TBL] [Abstract][Full Text] [Related]
8. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells.
Karaçam S; Tunçer S
Probiotics Antimicrob Proteins; 2022 Dec; 14(6):995-1011. PubMed ID: 34080175
[TBL] [Abstract][Full Text] [Related]
9. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study.
Andaloro C; Santagati M; Stefani S; La Mantia I
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):879-887. PubMed ID: 30767047
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibitory effect of two commercial probiotics on chromogenic actinomycetes.
Gobbi E; De Francesco MA; Piccinelli G; Caruso A; Bardellini E; Majorana A
Eur Arch Paediatr Dent; 2020 Dec; 21(6):673-677. PubMed ID: 32034698
[TBL] [Abstract][Full Text] [Related]
11. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
12. Randomized Clinical Trial of Oral Probiotic
Salim HP; Mallikarjun SB; Raju S; Surendranath AR
Int J Clin Pediatr Dent; 2023; 16(2):259-263. PubMed ID: 37519958
[TBL] [Abstract][Full Text] [Related]
13. Cell-free supernatant of Streptococcus salivarius M18 impairs the pathogenic properties of Pseudomonas aeruginosa and Klebsiella pneumonia.
Tunçer S; Karaçam S
Arch Microbiol; 2020 Dec; 202(10):2825-2840. PubMed ID: 32747998
[TBL] [Abstract][Full Text] [Related]
14. A single-centre investigator-blinded randomised parallel group clinical trial to investigate the effect of probiotic strains
Kaklamanos EG; Nassar R; Kalfas S; Al Halabi M; Kowash M; Hannawi H; Hussein I; Salami A; Hassan A; Senok AC
BMJ Open; 2019 Sep; 9(9):e030638. PubMed ID: 31501124
[TBL] [Abstract][Full Text] [Related]
15. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy.
Manti S; Parisi GF; Papale M; Licari A; Salpietro C; Miraglia Del Giudice M; Marseglia GL; Leonardi S
Ital J Pediatr; 2020 Apr; 46(1):42. PubMed ID: 32245500
[TBL] [Abstract][Full Text] [Related]
16. Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
Sarlin S; Tejesvi MV; Turunen J; Vänni P; Pokka T; Renko M; Tapiainen T
Pediatr Infect Dis J; 2021 May; 40(5):394-402. PubMed ID: 33298762
[TBL] [Abstract][Full Text] [Related]
17. Effect of Oral Probiotic Streptococcus salivarius K12 on Group A Streptococcus Pharyngitis: A Pragmatic Trial in Schools.
Doyle H; Pierse N; Tiatia R; Williamson D; Baker M; Crane J
Pediatr Infect Dis J; 2018 Jul; 37(7):619-623. PubMed ID: 29189607
[TBL] [Abstract][Full Text] [Related]
18. Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study.
Vesty A; Gear K; Boutell S; Taylor MW; Douglas RG; Biswas K
Sci Rep; 2020 Aug; 10(1):13201. PubMed ID: 32764634
[TBL] [Abstract][Full Text] [Related]
19. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
[TBL] [Abstract][Full Text] [Related]
20. Antigingivitis and Antiplaque Effects of Oral Probiotic Containing the
Babina K; Salikhova D; Doroshina V; Makeeva I; Zaytsev A; Uvarichev M; Polyakova M; Novozhilova N
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
